VMP 13005311000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Efavirenz 600mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
BNF code 0503010ANAAAAAA
Virtual Therapeutic Moiety Efavirenz + Emtricitabine + Tenofovir disoproxil
Basis of preferred name Other
Date of name applicability 4 Jan 2018
Previous name Generic Atripla 600mg/200mg/245mg tablets
Basis of previous name Other
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Tenofovir disoproxil fumarate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 421203005
Strength value numerator 245.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Emtricitabine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Efavirenz
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 600.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Efavirenz 600mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Efavirenz 600mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Efavirenz 600mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Efavirenz 600mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback